Cargando…
The Potential and Hurdles of Targeted Alpha Therapy – Clinical Trials and Beyond
This article presents a general discussion on what has been achieved so far and on the possible future developments of targeted alpha (α)-particle therapy (TAT). Clinical applications and potential benefits of TAT are addressed as well as the drawbacks, such as the limited availability of relevant r...
Autores principales: | Elgqvist, Jörgen, Frost, Sofia, Pouget, Jean-Pierre, Albertsson, Per |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890691/ https://www.ncbi.nlm.nih.gov/pubmed/24459634 http://dx.doi.org/10.3389/fonc.2013.00324 |
Ejemplares similares
-
Targeting Prostate Cancer Stem Cells with Alpha-Particle Therapy
por: Ceder, Jens, et al.
Publicado: (2017) -
Revisiting the Radiobiology of Targeted Alpha Therapy
por: Pouget, Jean-Pierre, et al.
Publicado: (2021) -
Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles
por: Furfaro, Lucy L., et al.
Publicado: (2018) -
Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications—Focus on Prostate and Breast Cancer
por: Elgqvist, Jörgen
Publicado: (2017) -
CAR-T cell therapy in myeloma: hopes and hurdles
por: Harousseau, Jean Luc
Publicado: (2023)